These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 37748907)

  • 1. Erythrocytosis in Gender-Affirming Care With Testosterone.
    Porat AT; Ellwood M; Rodina M; Dianat S
    Ann Fam Med; 2023; 21(5):403-407. PubMed ID: 37748907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythrocytosis Is Rare With Exogenous Testosterone in Gender-Affirming Hormone Therapy.
    Krishnamurthy N; Slack DJ; Kyweluk M; Cullen O; Kirkley J; Safer JD
    J Clin Endocrinol Metab; 2024 Apr; 109(5):1285-1290. PubMed ID: 38011684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laboratory Changes During Gender-Affirming Hormone Therapy in Transgender Adolescents.
    Millington K; Lee JY; Olson-Kennedy J; Garofalo R; Rosenthal SM; Chan YM
    Pediatrics; 2024 May; 153(5):. PubMed ID: 38567424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythrocytosis in a Large Cohort of Trans Men Using Testosterone: A Long-Term Follow-Up Study on Prevalence, Determinants, and Exposure Years.
    Madsen MC; van Dijk D; Wiepjes CM; Conemans EB; Thijs A; den Heijer M
    J Clin Endocrinol Metab; 2021 May; 106(6):1710-1717. PubMed ID: 33599731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of erythrocytosis in transgender individuals undergoing testosterone therapy: a systematic review.
    Scala A; Graziani A; Vianello F; Ferlin A; Garolla A;
    Minerva Endocrinol (Torino); 2024 Jun; 49(2):205-216. PubMed ID: 39028210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated Dihydrotestosterone is Associated with Testosterone Induced Erythrocytosis.
    Aghazadeh M; Pastuszak AW; Johnson WG; McIntyre MG; Hsieh TM; Lipshultz LI
    J Urol; 2015 Jul; 194(1):160-5. PubMed ID: 25596360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased risk of erythrocytosis in men with type 2 diabetes treated with combined sodium-glucose cotransporter-2 inhibitor and testosterone replacement therapy.
    Gosmanov AR; Gemoets DE; Schumacher KA
    J Endocrinol Invest; 2024 Oct; 47(10):2615-2621. PubMed ID: 38536657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythrocytosis and thromboembolic events in transgender individuals receiving gender-affirming testosterone.
    Oakes M; Arastu A; Kato C; Somers J; Holly HD; Elstrott BK; Dy GW; Kohs TCL; Patel RR; McCarty OJT; DeLoughery TG; Milano C; Raghunathan V; Shatzel JJ
    Thromb Res; 2021 Nov; 207():96-98. PubMed ID: 34592628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of testosterone formulations on hematocrit in transgender individuals: A systematic review.
    Okano SHP; Braga GC; Cantelli DAL; Filho LASP; Brito LGO; Lara LADS
    Andrology; 2024 Jul; ():. PubMed ID: 39011565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormone Concentrations in Transgender Women Who Self-Prescribe Gender Affirming Hormone Therapy: A Retrospective Study.
    Salakphet T; Mattawanon N; Manojai N; Muangmool T; Tangpricha V
    J Sex Med; 2022 May; 19(5):864-871. PubMed ID: 35379590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and rapid efficacy of guideline-based gender-affirming hormone therapy: an analysis of 388 individuals diagnosed with gender dysphoria.
    Meyer G; Mayer M; Mondorf A; Flügel AK; Herrmann E; Bojunga J
    Eur J Endocrinol; 2020 Feb; 182(2):149-156. PubMed ID: 31751300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective evaluation of hematocrit in gender-affirming hormone treatment: results from European Network for the Investigation of Gender Incongruence.
    Defreyne J; Vantomme B; Van Caenegem E; Wierckx K; De Blok CJM; Klaver M; Nota NM; Van Dijk D; Wiepjes CM; Den Heijer M; T'Sjoen G
    Andrology; 2018 May; 6(3):446-454. PubMed ID: 29602229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testosterone therapy and secondary erythrocytosis.
    White J; Petrella F; Ory J
    Int J Impot Res; 2022 Nov; 34(7):693-697. PubMed ID: 34987178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SERUM HORMONE CONCENTRATIONS IN TRANSGENDER INDIVIDUALS RECEIVING GENDER-AFFIRMING HORMONE THERAPY: A LONGITUDINAL RETROSPECTIVE COHORT STUDY.
    Chantrapanichkul P; Stevenson MO; Suppakitjanusant P; Goodman M; Tangpricha V
    Endocr Pract; 2021 Jan; 27(1):27-33. PubMed ID: 33471729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombotic risk associated with gender-affirming hormone therapy.
    Mullins TLK; Mullins ES
    J Thromb Haemost; 2024 Aug; 22(8):2129-2139. PubMed ID: 38795871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal Changes in Liver Enzyme Levels Among Transgender People Receiving Gender Affirming Hormone Therapy.
    Hashemi L; Zhang Q; Getahun D; Jasuja GK; McCracken C; Pisegna J; Roblin D; Silverberg MJ; Tangpricha V; Vupputuri S; Goodman M
    J Sex Med; 2021 Sep; 18(9):1662-1675. PubMed ID: 34366264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hematocrit Response and Risk Factors for Significant Hematocrit Elevation with Implantable Testosterone Pellets.
    Hayden RP; Bennett NE; Tanrikut C
    J Urol; 2016 Dec; 196(6):1715-1720. PubMed ID: 27287525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gender affirming hormonal treatment in Danish transgender persons: A nationwide register-based study.
    Glintborg D; Rubin KH; Kristensen SB; Lidegaard Ø; T'Sjoen G; Hilden M; Andersen MS
    Andrology; 2022 Jul; 10(5):885-893. PubMed ID: 35366390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of Erythrocytosis in Men Receiving Testosterone Therapy: Clinical Consultation Guide.
    Agrawal P; Singh SM; Kohn T
    Eur Urol Focus; 2023 Jan; 9(1):20-21. PubMed ID: 36335038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Which U.S. States' Medicaid Programs Provide Coverage for Gender-Affirming Hormone Therapy and Gender-Affirming Genital Surgery for Transgender Patients?: A State-by-State Review, and a Study Detailing the Patient Experience to Confirm Coverage of Services.
    Zaliznyak M; Jung EE; Bresee C; Garcia MM
    J Sex Med; 2021 Feb; 18(2):410-422. PubMed ID: 33422448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.